It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2010.
2010 | Hyderabad, Telangana, India | ActiveSadanjana Pharma Private Limited, a active private limited company, was established on 28 July 2010 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233TG2010PTC069709. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Venugopala Raju Dandu (Director), Pathapati Venkata Satyanarayana Raju (Director). Past directors included Pathapati Rajya Lakshmi, Mohan Rama Subba Rao Gowthu. It holds no open charges and ₹1.15 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at P.No 141, Sy No-44/1, Flat No-201,Sribalaji Towers Above Canara Bank,Mathrusri Nagar, Miyap, Ur, Hyderabad, Telangana, 500049.
U24233TG2010PTC069709
069709
28 July 2010
₹1.00 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sadanjana Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venugopala Raju Dandu | Director | 28 Jul 2010 | Current |
| Pathapati Venkata Satyanarayana Raju | Director | 28 Jul 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 06 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sadanjana Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.29% decrease. The company also saw a substantial improvement in profitability, with a 47.58% increase in profit. The company's net worth Soared by an impressive increase of 68.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sadanjana Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹11,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Sep 2014 | Punjab National Bank | ₹1.45 M | Satisfied |
| 13 Nov 2013 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Sadanjana Pharma has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sadanjana Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sadanjana Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sadanjana Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sadanjana Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity A charge registered on 13 Nov 2013 via Charge ID 10461433 with Axis Bank Limited was fully satisfied on 24 Jul 2023. was completed.
A charge with Axis Bank Limited of Rs. 10.00 M registered on 13 Nov 2013 with Charge ID 10461433 was modified on 21 Oct 2020. was recorded as a recent event.
A charge registered on 19 Sep 2014 via Charge ID 10532802 with Punjab National Bank was fully satisfied on 16 Aug 2019. was recorded as a recent event.
Progress on A charge with Punjab National Bank amounted to Rs. 1.45 M with Charge ID 10532802 was registered on 19 Sep 2014. was documented.
The CIN of Sadanjana Pharma Private Limited is U24233TG2010PTC069709.
Sadanjana Pharma Private Limited is headquartered at P.No 141, Sy No-44/1, Flat No-201,Sribalaji Towers Above Canara Bank,Mathrusri Nagar, Miyap, Ur, Hyderabad, Telangana, 500049.
Sadanjana Pharma Private Limited was incorporated on 28 July 2010.
The current directors of Sadanjana Pharma Private Limited are
The primary industry of Sadanjana Pharma Private Limited is Trade.
Sadanjana Pharma Private Limited is unlisted.
The authorized capital of Sadanjana Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Sadanjana Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX